市場調査レポート
商品コード
1267550

臨床検査サービスの世界市場 2023-2027

Global Clinical Laboratory Services Market 2023-2027

出版日: | 発行: TechNavio | ページ情報: 英文 178 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.55円
臨床検査サービスの世界市場 2023-2027
出版日: 2023年04月11日
発行: TechNavio
ページ情報: 英文 178 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、臨床検査サービス市場をモニターしており、2022年から2027年の間に1,474億4,000万米ドル、予測期間中のCAGRは10.25%で成長すると予測しています。

当レポートでは、臨床検査サービス市場について、全体的な分析、市場規模と予測、動向、成長促進要因・課題、さらに約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新の動向と促進要因、市場全体の環境に関する最新の分析を提供しています。市場は、老年人口の増加、慢性疾患の蔓延、自動化とラボラトリーロボットの登場によって牽引されています。

本調査では、今後数年間の臨床検査サービス市場の成長を促進する主な理由の1つとして、予防ヘルスケアの導入が増加していることを挙げています。また、企業のウェルネスプログラムの出現や、リアルタイムかつデジタル化された治療への注目が高まっていることも、市場の大きな需要につながると考えられます。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 市場情勢

  • 市場エコシステム

第3章 市場規模

  • 市場の定義
  • 市場別分析
  • 市場規模 2022
  • 市場の見通し 2022-2027

第4章 市場規模実績

  • 臨床検査サービスの世界市場 2017-2021
  • エンドユーザーセグメント分析 2017-2021
  • 用途別分析 2017-2021
  • 地域別分析 2017-2021
  • 国別分析 2017-2021

第5章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第6章 市場セグメンテーション:エンドユーザー別

  • 市場セグメント
  • 比較:エンドユーザー別
  • 病院ベースの検査室:市場規模と予測 2022-2027
  • 独立型研究所:市場規模と予測 2022-2027
  • 診療所型研究所:市場規模と予測 2022-2027
  • 市場機会:エンドユーザー別

第7章 市場セグメンテーション:用途別

  • 市場セグメント
  • 比較:用途別
  • 生物分析および実験化学:市場規模と予測 2022-2027
  • 毒物学検査:市場規模と予測 2022-2027
  • 細胞・遺伝子治療:市場規模と予測 2022-2027
  • 前臨床および臨床試験:市場規模と予測 2022-2027
  • その他:市場規模と予測 2022-2027
  • 市場機会:用途別

第8章 顧客情勢

  • 顧客情勢の概要

第9章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米:市場規模と予測 2022-2027
  • 欧州:市場規模と予測 2022-2027
  • アジア:市場規模と予測 2022-2027
  • 世界のその他の地域:市場規模と予測 2022-2027
  • 米国:市場規模と予測 2022-2027
  • 英国:市場規模と予測 2022-2027
  • 中国:市場規模と予測 2022-2027
  • ドイツ:市場規模と予測 2022-2027
  • 日本:市場規模と予測 2022-2027
  • 地域情勢別市場機会

第10章 促進要因、課題、および動向

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場動向

第11章 ベンダー情勢

  • 概要
  • ベンダー情勢
  • 混乱の状況
  • 業界のリスク

第12章 ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • Abbott Laboratories
  • ARUP Laboratories
  • Bio Rad Laboratories Inc.
  • Cerba HealthCare
  • Charles River Laboratories International Inc.
  • Eurofins Scientific SE
  • Fresenius Medical Care AG and Co. KGaA
  • Illumina Inc.
  • Laboratory Corp. of America Holdings
  • NeoGenomics Laboratories Inc.
  • OPKO Health Inc.
  • QIAGEN NV
  • Quest Diagnostics Inc.
  • Siemens AG
  • Sonic Healthcare Ltd.

第13章 付録

図表

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Application
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits10: Parent market
  • Exhibits11: Market Characteristics
  • Exhibits12: Offerings of vendors included in the market definition
  • Exhibits13: Market segments
  • Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
  • Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
  • Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits18: Historic Market Size - Data Table on Global Clinical Laboratory services market 2017 - 2021 ($ billion)
  • Exhibits19: Historic Market Size - End-user Segment 2017 - 2021 ($ billion)
  • Exhibits20: Historic Market Size - Application Segment 2017 - 2021 ($ billion)
  • Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
  • Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
  • Exhibits23: Five forces analysis - Comparison between 2022 and 2027
  • Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • Exhibits29: Chart on Market condition - Five forces 2022 and 2027
  • Exhibits30: Chart on End-user - Market share 2022-2027 (%)
  • Exhibits31: Data Table on End-user - Market share 2022-2027 (%)
  • Exhibits32: Chart on Comparison by End-user
  • Exhibits33: Data Table on Comparison by End-user
  • Exhibits34: Chart on Hospital-based laboratories - Market size and forecast 2022-2027 ($ billion)
  • Exhibits35: Data Table on Hospital-based laboratories - Market size and forecast 2022-2027 ($ billion)
  • Exhibits36: Chart on Hospital-based laboratories - Year-over-year growth 2022-2027 (%)
  • Exhibits37: Data Table on Hospital-based laboratories - Year-over-year growth 2022-2027 (%)
  • Exhibits38: Chart on Stand-alone laboratories - Market size and forecast 2022-2027 ($ billion)
  • Exhibits39: Data Table on Stand-alone laboratories - Market size and forecast 2022-2027 ($ billion)
  • Exhibits40: Chart on Stand-alone laboratories - Year-over-year growth 2022-2027 (%)
  • Exhibits41: Data Table on Stand-alone laboratories - Year-over-year growth 2022-2027 (%)
  • Exhibits42: Chart on Clinic-based laboratories - Market size and forecast 2022-2027 ($ billion)
  • Exhibits43: Data Table on Clinic-based laboratories - Market size and forecast 2022-2027 ($ billion)
  • Exhibits44: Chart on Clinic-based laboratories - Year-over-year growth 2022-2027 (%)
  • Exhibits45: Data Table on Clinic-based laboratories - Year-over-year growth 2022-2027 (%)
  • Exhibits46: Market opportunity by End-user ($ billion)
  • Exhibits47: Data Table on Market opportunity by End-user ($ billion)
  • Exhibits48: Chart on Application - Market share 2022-2027 (%)
  • Exhibits49: Data Table on Application - Market share 2022-2027 (%)
  • Exhibits50: Chart on Comparison by Application
  • Exhibits51: Data Table on Comparison by Application
  • Exhibits52: Chart on Bioanalytical and lab chemistry - Market size and forecast 2022-2027 ($ billion)
  • Exhibits53: Data Table on Bioanalytical and lab chemistry - Market size and forecast 2022-2027 ($ billion)
  • Exhibits54: Chart on Bioanalytical and lab chemistry - Year-over-year growth 2022-2027 (%)
  • Exhibits55: Data Table on Bioanalytical and lab chemistry - Year-over-year growth 2022-2027 (%)
  • Exhibits56: Chart on Toxicology testing - Market size and forecast 2022-2027 ($ billion)
  • Exhibits57: Data Table on Toxicology testing - Market size and forecast 2022-2027 ($ billion)
  • Exhibits58: Chart on Toxicology testing - Year-over-year growth 2022-2027 (%)
  • Exhibits59: Data Table on Toxicology testing - Year-over-year growth 2022-2027 (%)
  • Exhibits60: Chart on Cell and gene therapy - Market size and forecast 2022-2027 ($ billion)
  • Exhibits61: Data Table on Cell and gene therapy - Market size and forecast 2022-2027 ($ billion)
  • Exhibits62: Chart on Cell and gene therapy - Year-over-year growth 2022-2027 (%)
  • Exhibits63: Data Table on Cell and gene therapy - Year-over-year growth 2022-2027 (%)
  • Exhibits64: Chart on Preclinical and clinical trial - Market size and forecast 2022-2027 ($ billion)
  • Exhibits65: Data Table on Preclinical and clinical trial - Market size and forecast 2022-2027 ($ billion)
  • Exhibits66: Chart on Preclinical and clinical trial - Year-over-year growth 2022-2027 (%)
  • Exhibits67: Data Table on Preclinical and clinical trial - Year-over-year growth 2022-2027 (%)
  • Exhibits68: Chart on Others - Market size and forecast 2022-2027 ($ billion)
  • Exhibits69: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
  • Exhibits70: Chart on Others - Year-over-year growth 2022-2027 (%)
  • Exhibits71: Data Table on Others - Year-over-year growth 2022-2027 (%)
  • Exhibits72: Market opportunity by Application ($ billion)
  • Exhibits73: Data Table on Market opportunity by Application ($ billion)
  • Exhibits74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits75: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibits76: Data Table on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibits77: Chart on Geographic comparison
  • Exhibits78: Data Table on Geographic comparison
  • Exhibits79: Chart on North America - Market size and forecast 2022-2027 ($ billion)
  • Exhibits80: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
  • Exhibits81: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits82: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits83: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
  • Exhibits84: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
  • Exhibits85: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits86: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits87: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
  • Exhibits88: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
  • Exhibits89: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits90: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits91: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
  • Exhibits92: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
  • Exhibits93: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits94: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits95: Chart on US - Market size and forecast 2022-2027 ($ billion)
  • Exhibits96: Data Table on US - Market size and forecast 2022-2027 ($ billion)
  • Exhibits97: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibits98: Data Table on US - Year-over-year growth 2022-2027 (%)
  • Exhibits99: Chart on UK - Market size and forecast 2022-2027 ($ billion)
  • Exhibits100: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
  • Exhibits101: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibits102: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • Exhibits103: Chart on China - Market size and forecast 2022-2027 ($ billion)
  • Exhibits104: Data Table on China - Market size and forecast 2022-2027 ($ billion)
  • Exhibits105: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibits106: Data Table on China - Year-over-year growth 2022-2027 (%)
  • Exhibits107: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
  • Exhibits108: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
  • Exhibits109: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibits110: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibits111: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
  • Exhibits112: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
  • Exhibits113: Chart on Japan - Year-over-year growth 2022-2027 (%)
  • Exhibits114: Data Table on Japan - Year-over-year growth 2022-2027 (%)
  • Exhibits115: Market opportunity By Geographical Landscape ($ billion)
  • Exhibits116: Data Tables on Market opportunity By Geographical Landscape ($ billion)
  • Exhibits117: Impact of drivers and challenges in 2022 and 2027
  • Exhibits118: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits119: Overview on factors of disruption
  • Exhibits120: Impact of key risks on business
  • Exhibits121: Vendors covered
  • Exhibits122: Matrix on vendor position and classification
  • Exhibits123: Abbott Laboratories - Overview
  • Exhibits124: Abbott Laboratories - Business segments
  • Exhibits125: Abbott Laboratories - Key news
  • Exhibits126: Abbott Laboratories - Key offerings
  • Exhibits127: Abbott Laboratories - Segment focus
  • Exhibits128: ARUP Laboratories - Overview
  • Exhibits129: ARUP Laboratories - Product / Service
  • Exhibits130: ARUP Laboratories - Key offerings
  • Exhibits131: Bio Rad Laboratories Inc. - Overview
  • Exhibits132: Bio Rad Laboratories Inc. - Business segments
  • Exhibits133: Bio Rad Laboratories Inc. - Key news
  • Exhibits134: Bio Rad Laboratories Inc. - Key offerings
  • Exhibits135: Bio Rad Laboratories Inc. - Segment focus
  • Exhibits136: Cerba HealthCare - Overview
  • Exhibits137: Cerba HealthCare - Product / Service
  • Exhibits138: Cerba HealthCare - Key offerings
  • Exhibits139: Charles River Laboratories International Inc. - Overview
  • Exhibits140: Charles River Laboratories International Inc. - Business segments
  • Exhibits141: Charles River Laboratories International Inc. - Key news
  • Exhibits142: Charles River Laboratories International Inc. - Key offerings
  • Exhibits143: Charles River Laboratories International Inc. - Segment focus
  • Exhibits144: Eurofins Scientific SE - Overview
  • Exhibits145: Eurofins Scientific SE - Business segments
  • Exhibits146: Eurofins Scientific SE - Key news
  • Exhibits147: Eurofins Scientific SE - Key offerings
  • Exhibits148: Eurofins Scientific SE - Segment focus
  • Exhibits149: Fresenius Medical Care AG and Co. KGaA - Overview
  • Exhibits150: Fresenius Medical Care AG and Co. KGaA - Business segments
  • Exhibits151: Fresenius Medical Care AG and Co. KGaA - Key news
  • Exhibits152: Fresenius Medical Care AG and Co. KGaA - Key offerings
  • Exhibits153: Fresenius Medical Care AG and Co. KGaA - Segment focus
  • Exhibits154: Illumina Inc. - Overview
  • Exhibits155: Illumina Inc. - Business segments
  • Exhibits156: Illumina Inc. - Key news
  • Exhibits157: Illumina Inc. - Key offerings
  • Exhibits158: Illumina Inc. - Segment focus
  • Exhibits159: Laboratory Corp. of America Holdings - Overview
  • Exhibits160: Laboratory Corp. of America Holdings - Business segments
  • Exhibits161: Laboratory Corp. of America Holdings - Key news
  • Exhibits162: Laboratory Corp. of America Holdings - Key offerings
  • Exhibits163: Laboratory Corp. of America Holdings - Segment focus
  • Exhibits164: NeoGenomics Laboratories Inc. - Overview
  • Exhibits165: NeoGenomics Laboratories Inc. - Business segments
  • Exhibits166: NeoGenomics Laboratories Inc. - Key news
  • Exhibits167: NeoGenomics Laboratories Inc. - Key offerings
  • Exhibits168: NeoGenomics Laboratories Inc. - Segment focus
  • Exhibits169: OPKO Health Inc. - Overview
  • Exhibits170: OPKO Health Inc. - Business segments
  • Exhibits171: OPKO Health Inc. - Key offerings
  • Exhibits172: OPKO Health Inc. - Segment focus
  • Exhibits173: QIAGEN NV - Overview
  • Exhibits174: QIAGEN NV - Product / Service
  • Exhibits175: QIAGEN NV - Key news
  • Exhibits176: QIAGEN NV - Key offerings
  • Exhibits177: Quest Diagnostics Inc. - Overview
  • Exhibits178: Quest Diagnostics Inc. - Business segments
  • Exhibits179: Quest Diagnostics Inc. - Key offerings
  • Exhibits180: Quest Diagnostics Inc. - Segment focus
  • Exhibits181: Siemens AG - Overview
  • Exhibits182: Siemens AG - Business segments
  • Exhibits183: Siemens AG - Key news
  • Exhibits184: Siemens AG - Key offerings
  • Exhibits185: Siemens AG - Segment focus
  • Exhibits186: Sonic Healthcare Ltd. - Overview
  • Exhibits187: Sonic Healthcare Ltd. - Business segments
  • Exhibits188: Sonic Healthcare Ltd. - Key offerings
  • Exhibits189: Sonic Healthcare Ltd. - Segment focus
  • Exhibits190: Inclusions checklist
  • Exhibits191: Exclusions checklist
  • Exhibits192: Currency conversion rates for US$
  • Exhibits193: Research methodology
  • Exhibits194: Validation techniques employed for market sizing
  • Exhibits195: Information sources
  • Exhibits196: List of abbreviations
目次
Product Code: IRTNTR46517

Technavio has been monitoring the clinical laboratory services market and is forecast to grow by $147.44 bn during 2022-2027, accelerating at a CAGR of 10.25% during the forecast period. Our report on the clinical laboratory services market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growth in the geriatric population, the increasing prevalence of chronic diseases, and the advent of automation and laboratory robotics.

Technavio's clinical laboratory services market is segmented as below:

By End-user

  • Hospital-based laboratories
  • Stand-alone laboratories
  • Clinic-based laboratories

By Application

  • Bioanalytical and lab chemistry
  • Toxicology testing
  • Cell and gene therapy
  • Preclinical and clinical trial
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the increasing adoption of preventive healthcare as one of the prime reasons driving the clinical laboratory services market growth during the next few years. Also, the emergence of corporate wellness programs and increasing focus on real-time and digitalized treatment will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the clinical laboratory services market covers the following areas:

  • Clinical laboratory services market sizing
  • Clinical laboratory services market forecast
  • Clinical laboratory services market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading clinical laboratory services market vendors that include Abbott Laboratories, AP Moller Holding AS, ARUP Laboratories, Bio Rad Laboratories Inc., Cerba HealthCare, Charles River Laboratories International Inc., Enzo Clinical Labs, Eurofins Scientific SE, Fresenius Medical Care AG and Co. KGaA, Genova Diagnostics Inc., HU Group Holdings Inc., Illumina Inc., Laboratory Corp. of America Holdings, NeoGenomics Laboratories Inc., OPKO Health Inc., QIAGEN NV, Quest Diagnostics Inc., Siemens AG, Sonic Healthcare Ltd., and SYNLAB International GmbH. Also, the clinical laboratory services market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 13: Market segments
  • 3.3 Market size 2022
  • 3.4 Market outlook: Forecast for 2022-2027
  • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

  • 4.1 Global Clinical Laboratory services market 2017 - 2021
  • Exhibit 18: Historic Market Size - Data Table on Global Clinical Laboratory services market 2017 - 2021 ($ billion)
  • 4.2 End-user Segment Analysis 2017 - 2021
  • Exhibit 19: Historic Market Size - End-user Segment 2017 - 2021 ($ billion)
  • 4.3 Application Segment Analysis 2017 - 2021
  • Exhibit 20: Historic Market Size - Application Segment 2017 - 2021 ($ billion)
  • 4.4 Geography Segment Analysis 2017 - 2021
  • Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
  • 4.5 Country Segment Analysis 2017 - 2021
  • Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)

5 Five Forces Analysis

  • 5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
  • 5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • 5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • 5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • 5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • 5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • 5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by End-user

  • 6.1 Market segments
  • Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
  • Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
  • 6.2 Comparison by End-user
  • Exhibit 32: Chart on Comparison by End-user
  • Exhibit 33: Data Table on Comparison by End-user
  • 6.3 Hospital-based laboratories - Market size and forecast 2022-2027
  • Exhibit 34: Chart on Hospital-based laboratories - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 35: Data Table on Hospital-based laboratories - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 36: Chart on Hospital-based laboratories - Year-over-year growth 2022-2027 (%)
  • Exhibit 37: Data Table on Hospital-based laboratories - Year-over-year growth 2022-2027 (%)
  • 6.4 Stand-alone laboratories - Market size and forecast 2022-2027
  • Exhibit 38: Chart on Stand-alone laboratories - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 39: Data Table on Stand-alone laboratories - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 40: Chart on Stand-alone laboratories - Year-over-year growth 2022-2027 (%)
  • Exhibit 41: Data Table on Stand-alone laboratories - Year-over-year growth 2022-2027 (%)
  • 6.5 Clinic-based laboratories - Market size and forecast 2022-2027
  • Exhibit 42: Chart on Clinic-based laboratories - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 43: Data Table on Clinic-based laboratories - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 44: Chart on Clinic-based laboratories - Year-over-year growth 2022-2027 (%)
  • Exhibit 45: Data Table on Clinic-based laboratories - Year-over-year growth 2022-2027 (%)
  • 6.6 Market opportunity by End-user
  • Exhibit 46: Market opportunity by End-user ($ billion)
  • Exhibit 47: Data Table on Market opportunity by End-user ($ billion)

7 Market Segmentation by Application

  • 7.1 Market segments
  • Exhibit 48: Chart on Application - Market share 2022-2027 (%)
  • Exhibit 49: Data Table on Application - Market share 2022-2027 (%)
  • 7.2 Comparison by Application
  • Exhibit 50: Chart on Comparison by Application
  • Exhibit 51: Data Table on Comparison by Application
  • 7.3 Bioanalytical and lab chemistry - Market size and forecast 2022-2027
  • Exhibit 52: Chart on Bioanalytical and lab chemistry - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 53: Data Table on Bioanalytical and lab chemistry - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 54: Chart on Bioanalytical and lab chemistry - Year-over-year growth 2022-2027 (%)
  • Exhibit 55: Data Table on Bioanalytical and lab chemistry - Year-over-year growth 2022-2027 (%)
  • 7.4 Toxicology testing - Market size and forecast 2022-2027
  • Exhibit 56: Chart on Toxicology testing - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 57: Data Table on Toxicology testing - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 58: Chart on Toxicology testing - Year-over-year growth 2022-2027 (%)
  • Exhibit 59: Data Table on Toxicology testing - Year-over-year growth 2022-2027 (%)
  • 7.5 Cell and gene therapy - Market size and forecast 2022-2027
  • Exhibit 60: Chart on Cell and gene therapy - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 61: Data Table on Cell and gene therapy - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 62: Chart on Cell and gene therapy - Year-over-year growth 2022-2027 (%)
  • Exhibit 63: Data Table on Cell and gene therapy - Year-over-year growth 2022-2027 (%)
  • 7.6 Preclinical and clinical trial - Market size and forecast 2022-2027
  • Exhibit 64: Chart on Preclinical and clinical trial - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 65: Data Table on Preclinical and clinical trial - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 66: Chart on Preclinical and clinical trial - Year-over-year growth 2022-2027 (%)
  • Exhibit 67: Data Table on Preclinical and clinical trial - Year-over-year growth 2022-2027 (%)
  • 7.7 Others - Market size and forecast 2022-2027
  • Exhibit 68: Chart on Others - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 69: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 70: Chart on Others - Year-over-year growth 2022-2027 (%)
  • Exhibit 71: Data Table on Others - Year-over-year growth 2022-2027 (%)
  • 7.8 Market opportunity by Application
  • Exhibit 72: Market opportunity by Application ($ billion)
  • Exhibit 73: Data Table on Market opportunity by Application ($ billion)

8 Customer Landscape

  • 8.1 Customer landscape overview
  • Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • Exhibit 75: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibit 76: Data Table on Market share By Geographical Landscape 2022-2027 (%)
  • 9.2 Geographic comparison
  • Exhibit 77: Chart on Geographic comparison
  • Exhibit 78: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2022-2027
  • Exhibit 79: Chart on North America - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 80: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 81: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibit 82: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • 9.4 Europe - Market size and forecast 2022-2027
  • Exhibit 83: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 84: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 85: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibit 86: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • 9.5 Asia - Market size and forecast 2022-2027
  • Exhibit 87: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 88: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 89: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibit 90: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
  • Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • 9.7 US - Market size and forecast 2022-2027
  • Exhibit 95: Chart on US - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 96: Data Table on US - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 97: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibit 98: Data Table on US - Year-over-year growth 2022-2027 (%)
  • 9.8 UK - Market size and forecast 2022-2027
  • Exhibit 99: Chart on UK - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 100: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 101: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibit 102: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • 9.9 China - Market size and forecast 2022-2027
  • Exhibit 103: Chart on China - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 104: Data Table on China - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 105: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibit 106: Data Table on China - Year-over-year growth 2022-2027 (%)
  • 9.10 Germany - Market size and forecast 2022-2027
  • Exhibit 107: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 108: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 109: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibit 110: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • 9.11 Japan - Market size and forecast 2022-2027
  • Exhibit 111: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 112: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 113: Chart on Japan - Year-over-year growth 2022-2027 (%)
  • Exhibit 114: Data Table on Japan - Year-over-year growth 2022-2027 (%)
  • 9.12 Market opportunity By Geographical Landscape
  • Exhibit 115: Market opportunity By Geographical Landscape ($ billion)
  • Exhibit 116: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • Exhibit 117: Impact of drivers and challenges in 2022 and 2027
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
  • Exhibit 119: Overview on factors of disruption
  • 11.4 Industry risks
  • Exhibit 120: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
  • Exhibit 121: Vendors covered
  • 12.2 Market positioning of vendors
  • Exhibit 122: Matrix on vendor position and classification
  • 12.3 Abbott Laboratories
  • Exhibit 123: Abbott Laboratories - Overview
  • Exhibit 124: Abbott Laboratories - Business segments
  • Exhibit 125: Abbott Laboratories - Key news
  • Exhibit 126: Abbott Laboratories - Key offerings
  • Exhibit 127: Abbott Laboratories - Segment focus
  • 12.4 ARUP Laboratories
  • Exhibit 128: ARUP Laboratories - Overview
  • Exhibit 129: ARUP Laboratories - Product / Service
  • Exhibit 130: ARUP Laboratories - Key offerings
  • 12.5 Bio Rad Laboratories Inc.
  • Exhibit 131: Bio Rad Laboratories Inc. - Overview
  • Exhibit 132: Bio Rad Laboratories Inc. - Business segments
  • Exhibit 133: Bio Rad Laboratories Inc. - Key news
  • Exhibit 134: Bio Rad Laboratories Inc. - Key offerings
  • Exhibit 135: Bio Rad Laboratories Inc. - Segment focus
  • 12.6 Cerba HealthCare
  • Exhibit 136: Cerba HealthCare - Overview
  • Exhibit 137: Cerba HealthCare - Product / Service
  • Exhibit 138: Cerba HealthCare - Key offerings
  • 12.7 Charles River Laboratories International Inc.
  • Exhibit 139: Charles River Laboratories International Inc. - Overview
  • Exhibit 140: Charles River Laboratories International Inc. - Business segments
  • Exhibit 141: Charles River Laboratories International Inc. - Key news
  • Exhibit 142: Charles River Laboratories International Inc. - Key offerings
  • Exhibit 143: Charles River Laboratories International Inc. - Segment focus
  • 12.8 Eurofins Scientific SE
  • Exhibit 144: Eurofins Scientific SE - Overview
  • Exhibit 145: Eurofins Scientific SE - Business segments
  • Exhibit 146: Eurofins Scientific SE - Key news
  • Exhibit 147: Eurofins Scientific SE - Key offerings
  • Exhibit 148: Eurofins Scientific SE - Segment focus
  • 12.9 Fresenius Medical Care AG and Co. KGaA
  • Exhibit 149: Fresenius Medical Care AG and Co. KGaA - Overview
  • Exhibit 150: Fresenius Medical Care AG and Co. KGaA - Business segments
  • Exhibit 151: Fresenius Medical Care AG and Co. KGaA - Key news
  • Exhibit 152: Fresenius Medical Care AG and Co. KGaA - Key offerings
  • Exhibit 153: Fresenius Medical Care AG and Co. KGaA - Segment focus
  • 12.10 Illumina Inc.
  • Exhibit 154: Illumina Inc. - Overview
  • Exhibit 155: Illumina Inc. - Business segments
  • Exhibit 156: Illumina Inc. - Key news
  • Exhibit 157: Illumina Inc. - Key offerings
  • Exhibit 158: Illumina Inc. - Segment focus
  • 12.11 Laboratory Corp. of America Holdings
  • Exhibit 159: Laboratory Corp. of America Holdings - Overview
  • Exhibit 160: Laboratory Corp. of America Holdings - Business segments
  • Exhibit 161: Laboratory Corp. of America Holdings - Key news
  • Exhibit 162: Laboratory Corp. of America Holdings - Key offerings
  • Exhibit 163: Laboratory Corp. of America Holdings - Segment focus
  • 12.12 NeoGenomics Laboratories Inc.
  • Exhibit 164: NeoGenomics Laboratories Inc. - Overview
  • Exhibit 165: NeoGenomics Laboratories Inc. - Business segments
  • Exhibit 166: NeoGenomics Laboratories Inc. - Key news
  • Exhibit 167: NeoGenomics Laboratories Inc. - Key offerings
  • Exhibit 168: NeoGenomics Laboratories Inc. - Segment focus
  • 12.13 OPKO Health Inc.
  • Exhibit 169: OPKO Health Inc. - Overview
  • Exhibit 170: OPKO Health Inc. - Business segments
  • Exhibit 171: OPKO Health Inc. - Key offerings
  • Exhibit 172: OPKO Health Inc. - Segment focus
  • 12.14 QIAGEN NV
  • Exhibit 173: QIAGEN NV - Overview
  • Exhibit 174: QIAGEN NV - Product / Service
  • Exhibit 175: QIAGEN NV - Key news
  • Exhibit 176: QIAGEN NV - Key offerings
  • 12.15 Quest Diagnostics Inc.
  • Exhibit 177: Quest Diagnostics Inc. - Overview
  • Exhibit 178: Quest Diagnostics Inc. - Business segments
  • Exhibit 179: Quest Diagnostics Inc. - Key offerings
  • Exhibit 180: Quest Diagnostics Inc. - Segment focus
  • 12.16 Siemens AG
  • Exhibit 181: Siemens AG - Overview
  • Exhibit 182: Siemens AG - Business segments
  • Exhibit 183: Siemens AG - Key news
  • Exhibit 184: Siemens AG - Key offerings
  • Exhibit 185: Siemens AG - Segment focus
  • 12.17 Sonic Healthcare Ltd.
  • Exhibit 186: Sonic Healthcare Ltd. - Overview
  • Exhibit 187: Sonic Healthcare Ltd. - Business segments
  • Exhibit 188: Sonic Healthcare Ltd. - Key offerings
  • Exhibit 189: Sonic Healthcare Ltd. - Segment focus

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • Exhibit 190: Inclusions checklist
  • Exhibit 191: Exclusions checklist
  • 13.3 Currency conversion rates for US$
  • Exhibit 192: Currency conversion rates for US$
  • 13.4 Research methodology
  • Exhibit 193: Research methodology
  • Exhibit 194: Validation techniques employed for market sizing
  • Exhibit 195: Information sources
  • 13.5 List of abbreviations
  • Exhibit 196: List of abbreviations